• Je něco špatně v tomto záznamu ?

Is there a role for neoadjuvant therapies followed by radical cystectomy in oligometastatic bladder cancer

A. Cadenar, S. Mancon, SF. Shariat, D. D'Andrea

. 2025 ; 35 (2) : 189-193. [pub] 20250116

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc25009679

PURPOSE OF REVIEW: This review explores the potential role of neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) for oligometastatic bladder cancer (OMBC) treatment. We focused on extrapolating evidence from studies including lymph node-positive only and metastatic bladder cancer to address the key challenges and therapeutic strategies for OMBC. RECENT FINDINGS: Current evidence for NAC and RC in OMBC is limited, with most data derived from studies in locally advanced bladder cancer. NAC has shown efficacy in downstaging and improving survival in patients with locally advanced disease, but its benefits in OMBC remain speculative. Additionally, diagnostic uncertainties, particularly regarding the inclusion of pelvic lymph nodes and the role of FDG-PET/CT, pose significant challenges to accurate staging and treatment decisions. Recent studies highlight the potential of metastasis-directed therapy, but uncertainties remain on patient selection and treatment protocols for OMBC. SUMMARY: There is need for prospective studies to evaluate neoadjuvant systemic treatments and RC specifically in OMBC. Moreover, resolving current diagnostic challenges is crucial to avoid undertreatment due to inaccurate staging. Until more concrete evidence emerges, changes to standard treatment protocols should be approached with caution and offered only within trials.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009679
003      
CZ-PrNML
005      
20250429134547.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/MOU.0000000000001261 $2 doi
035    __
$a (PubMed)39820224
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Cadenar, Anna $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Vienna, Austria $u Department of Experimental and Clinical Medicine, University of Florence - Unit of Oncologic Minimally-Invasive Urology and Andrology, Careggi Hospital, Florence
245    10
$a Is there a role for neoadjuvant therapies followed by radical cystectomy in oligometastatic bladder cancer / $c A. Cadenar, S. Mancon, SF. Shariat, D. D'Andrea
520    9_
$a PURPOSE OF REVIEW: This review explores the potential role of neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) for oligometastatic bladder cancer (OMBC) treatment. We focused on extrapolating evidence from studies including lymph node-positive only and metastatic bladder cancer to address the key challenges and therapeutic strategies for OMBC. RECENT FINDINGS: Current evidence for NAC and RC in OMBC is limited, with most data derived from studies in locally advanced bladder cancer. NAC has shown efficacy in downstaging and improving survival in patients with locally advanced disease, but its benefits in OMBC remain speculative. Additionally, diagnostic uncertainties, particularly regarding the inclusion of pelvic lymph nodes and the role of FDG-PET/CT, pose significant challenges to accurate staging and treatment decisions. Recent studies highlight the potential of metastasis-directed therapy, but uncertainties remain on patient selection and treatment protocols for OMBC. SUMMARY: There is need for prospective studies to evaluate neoadjuvant systemic treatments and RC specifically in OMBC. Moreover, resolving current diagnostic challenges is crucial to avoid undertreatment due to inaccurate staging. Until more concrete evidence emerges, changes to standard treatment protocols should be approached with caution and offered only within trials.
650    _2
$a lidé $7 D006801
650    12
$a nádory močového měchýře $x patologie $x terapie $x chirurgie $7 D001749
650    12
$a neoadjuvantní terapie $x metody $7 D020360
650    12
$a cystektomie $x metody $7 D015653
650    _2
$a adjuvantní chemoterapie $x metody $7 D017024
650    _2
$a staging nádorů $7 D009367
650    _2
$a lymfatické metastázy $7 D008207
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Mancon, Stefano $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Vienna, Austria $u Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Vienna, Austria $u Department of Urology, Semmelweis University, Budapest, Hungary $u Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas $u Department of Urology, Weill Cornell Medical College, New York, New York, USA $u Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czechia, Czechia $u Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan $u Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria $u Research Center for Evidence Medicine, Urology Department Tabriz University of Medical Sciences, Tabriz, Iran
700    1_
$a D'Andrea, David $u Department of Urology, Comprehensive Cancer Center Medical University Vienna, Vienna General Hospital, Vienna, Austria
773    0_
$w MED00001296 $t Current opinion in urology $x 1473-6586 $g Roč. 35, č. 2 (2025), s. 189-193
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39820224 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134543 $b ABA008
999    __
$a ok $b bmc $g 2311197 $s 1246760
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 35 $c 2 $d 189-193 $e 20250116 $i 1473-6586 $m Current opinion in urology $n Curr Opin Urol $x MED00001296
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Možnosti archivace